Introduction: screening and brief intervention

Same author

Impacts of personal or family COVID-19 infection on health-related quality of life among patients with opioid use disorder.

Journal of substance use·2026

Same author

"The Sky Didn't Fall": Patient and Clinician Experiences With Increased Buprenorphine Prescription Lengths During Pandemic-related Telehealth Expansion.

Journal of addiction medicine·2026

Same author

Associations between COVID impact domains and time to buprenorphine treatment disengagement.

The American journal of drug and alcohol abuse·2025

Same author

Patient and Provider Perspectives on the Elimination of Urine Drug Testing in Office-Based Addiction Treatment.

Substance use & addiction journal·2025

Same author

Pain and alcohol consumption among people living with HIV: examining the moderating roles of depression and social support.

Alcohol (Fayetteville, N.Y.)·2025

Same author

Patient and clinician experiences with the implementation of telemedicine and related adaptations in office-based buprenorphine treatment during the COVID-19 pandemic: a qualitative study.

Addiction science & clinical practice·2025

Same journal

Association of MOUD ECHO Participation on Expansion of Buprenorphine Prescribing in Rural Primary Care.

Substance abuse·2023

Same journal

A Pragmatic, Person-Centered View of Cannabis in the United States: Pursuing Care That Transcends Beliefs.

Substance abuse·2023

Same journal

Research Priorities for Expansion of Opioid Use Disorder Treatment in the Community Pharmacy.

Substance abuse·2023

Same journal

Treatment Initiation, Substance Use Trajectories, and the Social Determinants of Health in Persons Living With HIV Seeking Medication for Opioid Use Disorder.

Substance abuse·2023

Same journal

Advancing Proficiencies for Health Professionals in the Treatment of Tobacco Use Among Marginalized Communities: Development of a Competency-Based Curriculum and Virtual Workshop.

Substance abuse·2023

Same journal

Care Practices of Mental Health Clinical Pharmacist Practitioners Within an Interdisciplinary Primary Care Model for Patients With Substance Use Disorders.

Substance abuse·2023

Related Experiment Videos

Introduction: screening and brief intervention

Related Concept Videos

Impacts of personal or family COVID-19 infection on health-related quality of life among patients with opioid use disorder.

"The Sky Didn't Fall": Patient and Clinician Experiences With Increased Buprenorphine Prescription Lengths During Pandemic-related Telehealth Expansion.

Associations between COVID impact domains and time to buprenorphine treatment disengagement.

Patient and Provider Perspectives on the Elimination of Urine Drug Testing in Office-Based Addiction Treatment.

Pain and alcohol consumption among people living with HIV: examining the moderating roles of depression and social support.

Patient and clinician experiences with the implementation of telemedicine and related adaptations in office-based buprenorphine treatment during the COVID-19 pandemic: a qualitative study.

Association of MOUD ECHO Participation on Expansion of Buprenorphine Prescribing in Rural Primary Care.

A Pragmatic, Person-Centered View of Cannabis in the United States: Pursuing Care That Transcends Beliefs.

Research Priorities for Expansion of Opioid Use Disorder Treatment in the Community Pharmacy.

Treatment Initiation, Substance Use Trajectories, and the Social Determinants of Health in Persons Living With HIV Seeking Medication for Opioid Use Disorder.

Advancing Proficiencies for Health Professionals in the Treatment of Tobacco Use Among Marginalized Communities: Development of a Competency-Based Curriculum and Virtual Workshop.

Care Practices of Mental Health Clinical Pharmacist Practitioners Within an Interdisciplinary Primary Care Model for Patients With Substance Use Disorders.

Related Experiment Videos

Introduction: screening and brief intervention

Related Concept Videos

Related Articles

Impacts of personal or family COVID-19 infection on health-related quality of life among patients with opioid use disorder.

"The Sky Didn't Fall": Patient and Clinician Experiences With Increased Buprenorphine Prescription Lengths During Pandemic-related Telehealth Expansion.

Associations between COVID impact domains and time to buprenorphine treatment disengagement.

Patient and Provider Perspectives on the Elimination of Urine Drug Testing in Office-Based Addiction Treatment.

Pain and alcohol consumption among people living with HIV: examining the moderating roles of depression and social support.

Patient and clinician experiences with the implementation of telemedicine and related adaptations in office-based buprenorphine treatment during the COVID-19 pandemic: a qualitative study.

Association of MOUD ECHO Participation on Expansion of Buprenorphine Prescribing in Rural Primary Care.

A Pragmatic, Person-Centered View of Cannabis in the United States: Pursuing Care That Transcends Beliefs.

Research Priorities for Expansion of Opioid Use Disorder Treatment in the Community Pharmacy.

Treatment Initiation, Substance Use Trajectories, and the Social Determinants of Health in Persons Living With HIV Seeking Medication for Opioid Use Disorder.

Advancing Proficiencies for Health Professionals in the Treatment of Tobacco Use Among Marginalized Communities: Development of a Competency-Based Curriculum and Virtual Workshop.

Care Practices of Mental Health Clinical Pharmacist Practitioners Within an Interdisciplinary Primary Care Model for Patients With Substance Use Disorders.